Suppr超能文献

肿瘤坏死因子α阻断治疗成功应用于难治性结节病。

Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis.

作者信息

Ulbricht Kai U, Stoll Matthias, Bierwirth Janine, Witte Torsten, Schmidt Reinhold E

机构信息

Hannover Medical School, Hannover, Germany.

出版信息

Arthritis Rheum. 2003 Dec;48(12):3542-3. doi: 10.1002/art.11357.

Abstract

Sarcoidosis is a multisystemic disorder histologically characterized by a noncaseating granulomatous inflammatory process. The etiology remains unclear, but tumor necrosis factor alpha seems to play a crucial role. Herein we describe a patient with severe sarcoidosis involving the lung and liver. Various treatment regimens with azathioprine, methotrexate, cyclophosphamide, and pentoxifylline failed to control the disease. Therefore, salvage therapy with infliximab was commenced. Arthritis and pulmonary and liver involvement improved. We were then able to taper the corticosteroid treatment to a lower-dose regimen with no need for additional immunosuppressive treatment. To our knowledge, this is the first reported case of successful treatment of multiorgan sarcoidosis that was previously resistant to conventional therapy.

摘要

结节病是一种多系统疾病,组织学特征为非干酪样肉芽肿性炎症过程。病因尚不清楚,但肿瘤坏死因子α似乎起着关键作用。在此我们描述一位患有严重结节病累及肺和肝脏的患者。使用硫唑嘌呤、甲氨蝶呤、环磷酰胺和己酮可可碱的各种治疗方案均未能控制病情。因此,开始使用英夫利昔单抗进行挽救治疗。关节炎以及肺部和肝脏受累情况得到改善。然后我们能够将皮质类固醇治疗逐渐减至较低剂量方案,无需额外的免疫抑制治疗。据我们所知,这是首例成功治疗先前对传统疗法耐药的多器官结节病的报道病例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验